Overview

A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes

Status:
Completed
Trial end date:
2021-01-10
Target enrollment:
Participant gender:
Summary
This is a single center, double-blind, randomized trial in subjects with type 1 diabetes mellitus applying an adaptive design approach.
Phase:
Early Phase 1
Details
Lead Sponsor:
Abvance Therapeutics
Collaborator:
T1D Exchange, United States
Treatments:
Glucagon
Insulin
Insulin, Globin Zinc